INTELLIGENT BIO SOLUTIONS INC. Government Assistance Operating Income
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Government Assistance Operating Income of $677.78 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GovernmentAssistanceOperatingIncome · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. government assistance operating income for the quarter ending 2026-06-30 was $246.09K, a 35.89% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. government assistance operating income for the quarter ending 2026-03-31 was $165.69K, a 4.37% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. government assistance operating income for the quarter ending 2025-12-31 was $72.72K, a 45.59% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. government assistance operating income for the quarter ending 2025-09-30 was $193.27K, a 53.23% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. government assistance operating income for fiscal 2026 was $677.78K, a 17.03% decline from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. government assistance operating income for fiscal 2025 was $816.90K, a 92.31% increase from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. government assistance operating income for fiscal 2024 was $424.78K.
| Period end | Government Assistance Operating Income 3 month | Government Assistance Operating Income 6 month | Government Assistance Operating Income 9 month | Government Assistance Operating Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $246.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $411.79K derived: sum of 2 quarters · filed 2026-08-19 | $484.51K derived: sum of 3 quarters · filed 2026-08-19 | $677.78K 10-K · filed 2026-08-19 |
| 2026-03-31 | $165.69K 10-Q · filed 2026-05-13 | $238.41K derived: sum of 2 quarters · filed 2026-05-13 | $431.68K 10-Q · filed 2026-05-13 | $815.54K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $72.72K 10-Q · filed 2026-02-12 | $265.99K 10-Q · filed 2026-02-12 | $649.85K derived: sum of 3 quarters · filed 2026-08-19 | $823.12K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | $193.27K 10-Q · filed 2025-11-12 | $577.13K derived: sum of 2 quarters · filed 2026-08-19 | $750.40K derived: sum of 3 quarters · filed 2026-08-19 | $884.04K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $383.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $557.13K derived: sum of 2 quarters · filed 2026-08-19 | $690.77K derived: sum of 3 quarters · filed 2026-08-19 | $816.90K 10-K · filed 2026-08-19 |
| 2025-03-31 | $173.27K 10-Q · filed 2026-05-13 | $306.91K derived: sum of 2 quarters · filed 2026-05-13 | $433.04K 10-Q · filed 2026-05-13 | $510.90K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $133.64K 10-Q · filed 2026-02-12 | $259.77K 10-Q · filed 2026-02-12 | $337.63K derived: sum of 3 quarters · filed 2026-02-12 | $421.47K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $126.13K 10-Q · filed 2025-11-12 | $203.99K derived: sum of 2 quarters · filed 2025-11-12 | $287.83K derived: sum of 3 quarters · filed 2025-11-12 | $441.03K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $77.86K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $161.70K derived: sum of 2 quarters · filed 2025-08-15 | $314.90K derived: sum of 3 quarters · filed 2025-08-15 | $424.78K 10-K · filed 2025-08-15 |
| 2024-03-31 | $83.84K 10-Q · filed 2025-05-13 | $237.05K derived: sum of 2 quarters · filed 2025-05-13 | $346.92K 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $153.20K 10-Q · filed 2025-02-13 | $263.07K 10-Q · filed 2025-02-13 | ||
| 2023-09-30 | $109.87K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |